Amanote Research
Register
Sign In
PMS75 Annual Golimumab Utilization and Costs for Psoriatic Arthritis Patients Enrolled in Managed Care Plans
Value in Health
- United Kingdom
doi 10.1016/j.jval.2012.03.264
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
June 1, 2012
Authors
C. Carter
D. Smith
N. Tandon
Publisher
Elsevier BV
Related search
Efficacy and Safety of Intravenous Golimumab Through 1 Year in Patients With Active Psoriatic Arthritis
Arthritis Care and Research
Rheumatology
Annual Health Care Utilization and Costs in Cushing's Disease Patients in the United States
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Etanercept and Adalimumab Treatment Patterns in Psoriatic Arthritis Patients Enrolled in a Commercial Health Plan
Advances in Therapy
Medicine
Pharmacology
Outpatient Utilization by Infants Auto-Assigned to Medicaid Managed Care Plans
Maternal and Child Health Journal
Child Health
Epidemiology
Gynecology
Public Health
Perinatology
Environmental
Obstetrics
Pediatrics
Occupational Health
Do Managed Care Plans' Tiered Networks Lead to Inequities in Care for Minority Patients?
Health Affairs
Medicine
Health Policy
P146 Golimumab in Rheumatoid and Psoriatic Arthritis. The Relationship Between Minimum Serum Concentration, Anti-Golimumab Antibodies and Activity of Disease
Lung Cancer Costs by Treatment Strategy and Phase of Care Among Patients Enrolled in Medicare
Cancer Medicine
Cancer Research
Nuclear Medicine
Radiology
Imaging
Oncology
Peripheral Neuropathy in Patients With Psoriatic Arthritis
ScienceRise: Medical Science
Cardiovascular Risk in Patients With Psoriatic Arthritis
Terapevticheskii Arkhiv
Internal Medicine
Endocrinology
Metabolism
Diabetes
